SPRED2 and neoplasm: We previously demonstrated that SPRED2 is localized in the cytoplasm of non-tumor cells and that the presence of SPRED2 on cell membrane suppresses the progression of noninvasive papillary urothelial carcinoma, likely by inhibiting the RAS/RAF/ERK pathway [20].